Reynold Tan, PhD FDA

Reynold Tan has worked as a chemistry reviewer at FDA for the past 16 years. For the past 6 years, he has worked in FDA’s Office of Lifecycle Drug Products/Division of Liquid-Based Products as a Quality Assessment Lead (QAL).  As QAL, he oversees the drug product quality assessment of abbreviated new drug applications (ANDAs). He has assessed ANDAs primarily for injectable drug products. He has served on the FDA workgroup tasked with establishing guidelines for recommended vial fill volumes for injectables. Prior to reviewing ANDAs, he worked in FDA’s review division for over-the-counter (OTC) drug products, developing OTC drug monographs. Prior to FDA, he worked as an analytical research and development chemist for Knoll Pharmaceuticals. He received his Ph.D. in biochemistry from the University of Maryland, College Park in 2002 and his bachelor’s degree in biochemistry from the University of Pennsylvania in 1988.